Establishment Labs Holdings Inc. (ESTA) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-27

How it makes money

It earns revenue by selling silicone gel-filled breast implants and medical technologies through exclusive distributors and direct sales forces globally.

Since launching Motiva Implants in October 2010, the majority of revenue has been generated from sales of these silicone gel-filled breast implants. Revenue reached $211.1 million for the year ended December 31, 2025, compared to $166.0 million for the year ended December 31, 2024. Products are commercially available via exclusive distributors or a direct sales force in over 100 countries.

What protects it: the moat

Management claims that proprietary safety and design features differentiate its products and drive revenue growth, though competitors could develop superior alternatives.

The company relies on its technological features, such as SmoothSilk surfaces and RFID technology, to differentiate its products from competitors. However, management notes that competitors' new products may beat its products to market, be more effective, or render its offerings obsolete.

What growth costs

It incurs significant research and development expenses alongside financing activities such as inventory funding agreements and term loans.

In recent years, the company has incurred significant costs in connection with the research and development of Motiva Implants and the Mia Femtech technology. It also relies on external debt and inventory funding agreements, such as drawing $5 million under an inventory funding agreement and obtaining a $25 million term loan.

What could damage it

Disruptions or funding shortages at the regulatory agencies could delay product approvals and impair commercialization efforts.

The ability to review and approve new products can be affected by government budget and funding levels and executive actions. If regulatory agencies face prolonged disruptions, the company may fail to obtain timely clearances, which would impair its ability to scale commercial operations.

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Other companies in Medical Devices